Company / Free Cash Flow per Share
Tarsus Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.58
FY2025
5-year range
-$4.46 / $0.16
FY2021-FY2025
Trend
+76.5%
vs FY2024
Sector context
#93 of 192
Health Care
What the data says
At $-0.58, Tarsus Pharmaceuticals, Inc.'s free cash flow per share ranks #93 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $-4.46 in FY2023 to $0.16 in FY2021.
Based on SEC 10-K filings.
-0.58 in FY2025.
Improved from $-4.46 to $-0.58 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 192 in Health CareTop 48% of 192This company -$0.58 Sector average -$19.84
▼
+97.1% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 76.5% year-over-year.
- Ranks #93 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.58 | +76.5% |
| FY2024 | -$2.47 | +44.5% |
| FY2023 | -$4.46 | -3017.4% |
| FY2022 | $0.15 | -1.8% |
| FY2021 | $0.16 | +104.5% |
| FY2020 | -$3.48 | -113.6% |
| FY2019 | -$1.63 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026